We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LIN:NASDAQLinde plc analysis

Data as of Oct 19, 2026 - not real-time

Latest price
$498.43
Risk: low
3/10Low risk

Summary

At $498.43, Linde plc shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have gained 3.4%. RSI sits at 67.8, which reads as approaching overbought, and MACD momentum is bullish. Recent trading has carved out support near $455.27 and resistance around $502.14.
The shares look fair at 32.2 times earnings, though no sector average was available for comparison. Sell-side targets cluster 9.2% above the current quote. Revenue is growing at 9.3% on a 20.4% profit margin. The 1.28% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 14.8%, a beta of 0.05 and a maximum drawdown of 16.3%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 86 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 3/10 conviction on the long call.

Top market events

  • Linde reported USD 9.29 billion revenue in the second quarter, up 9.30 percent year over year. Linde
  • Sustainable Growth Advisers SGA , an investment management company, released its second-quarter 2026 investor letter...
  • Sirmium Capital recently released its quarterly Q3 2026 investor letter.

Market outlook

Short term

< 1 year

Positive

Model confidence4/104 out of 10

Key factors

  • Trading above the 200-day average of 489.46
  • MACD momentum is positive
  • RSI at 67.8 is in neutral territory

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading above the 200-day average of 489.46
  • Analyst targets imply +9.2% versus the current price
  • MACD momentum is positive

Long term

> 3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Analyst targets imply +9.2% versus the current price
  • Profit margin of 20.4% is healthy
  • P/E ratio of 32.2

Key metrics

Financial health

Revenue Growth9.30%
Profit Margin20.43%
P/E Ratio32.2
ROE18.40%
ROA7.16%
Debt/Equity68.95
P/B Ratio5.9
Op. Cash Flow$10.5B
Free Cash Flow$4.2B

Technical analysis

TrendNeutral
RSI67.8
Support$455.27
Resistance$502.14
MA 20$479.24
MA 50$478.77
MA 200$489.46
MACDBullish
VolumeStable
Fear & Greed Index85.73

Valuation

Fair Value$111.38
Target Price$544.15
Upside/Downside9.17%
GradeFair
TypeGrowth
Dividend Yield1.28%

Risk assessment

Beta0.05
Volatility14.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.